Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 689 of 1,261
  1. US 9364443

    Compositions and methods for drug delivery

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  2. US 9364438

    Process for producing solid particles

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  3. US 9365626

    Simukunin

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  4. US 9365621

    Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  5. US 9365604

    Oligomer-nucleoside phosphate conjugates

    Nektar Therapeutics · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  6. US 9365588

    Benzoxazines as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  7. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  8. US 9365602

    Sodium glucose co-transporter inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  9. US 9364471

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  10. US 9364557

    Fold-back diabody diphtheria toxin immunotoxin and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  11. US 9365540

    Benzimidazole derivatives as MCH receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  12. US 9364462

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  13. US 9365823

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  14. US 9365612

    Caspase inhibitors

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  15. US 2016159901

    DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 9, 2016 · Expires Jun 4, 2036

    granted
  16. EP 3027208

    DIAGNOSE UND THERAPIE VON KREBS MIT KREBSSTAMMZELLEN

    BIONTECH AG [DE] · Granted Jun 8, 2016 · Expires Jun 3, 2036

    granted
  17. US 9359313

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  18. US 9358306

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  19. US 9358204

    Formulations of viloxazine

    Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  20. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  21. US 9359290

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  22. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  23. US 9359285

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  24. US 9359598

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.